Antidiabetic agents aim to achieve normoglycemia and relieve diabetes symptoms, such as thirst, polyuria, weight loss, ketoacidosis. The long term goals are to prevent the development of or slow the progression of long term complications of the disease. Miscellaneous antidiabetic agents includes all antidiabetic agents not classified elsewhere.
Name | Updated |
---|---|
Teplizumab (Teplizumab [ tep-liz-ue-mab ]) | 12-Aug-2023 |